|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00660 WAI CHUN BIOTEC
Nominal 
0.092 0.000 (0.000%) | 2022/12 - Interim HKD($) | %Chg (Interim to Interim) | 2021/06 HKD($) | 2020/06 HKD($) | 2019/06 HKD($) | 2018/06 HKD($) | ||
| Turnover | 405,080,000 | 40.715% | 287,873,000 | 247,104,000 | 269,294,000 | 243,001,000 | |
| Cost of Sales | (378,389,000) | 46.023% | (259,129,000) | (221,939,000) | (252,238,000) | (234,675,000) | |
| Gross Profit | 26,691,000 | -7.142% | 28,744,000 | 25,165,000 | 17,056,000 | 8,326,000 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | (1,080,000) | 3,486,000 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | 67,000 | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (3,779,000) | -- | 2,863,000 | 7,759,000 | (3,491,000) | (5,546,000) | |
| Taxation | (1,529,000) | 42.631% | (1,072,000) | 0 | (77,000) | (58,000) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (2,523,000) | -59.729% | (6,265,000) | (7,682,000) | (1,979,000) | (1,125,000) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (7,831,000) | 75.034% | (4,474,000) | 77,000 | (5,547,000) | (6,729,000) | |
| Net Finance Costs / (Income) | 8,424,000 | 34.055% | 6,284,000 | 3,737,000 | 3,249,000 | 2,435,000 | |
| Depreciation & Amortisation | 5,267,000 | 5.742% | 4,981,000 | 2,400,000 | 2,571,000 | 2,772,000 | |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A | |
Market Valuation Indicators
| EPS (cts) | -4.700 | -- | -2.700 | 0.046 | -3.325 | -4.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | -0.280 | -- | -0.246 | -0.306 | -0.317 | -0.241 |
| Remarks: | Real time quote last updated: 28/09/2023 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -7,831,000 |
| %Change | 75.034% |
| EPS / (LPS) | HKD -0.047 |
| NBV Per Share ($) | HKD -0.280 |